Search results
AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to...
The Longview News-Journal· 4 days ago- Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
AbbVie joins psychedelic push, inks $2B+ next-gen neuro deal with Gilgamesh
FierceBiotech· 4 days agoAbbVie is wading into the waters of psychedelics, penning a pact with Gilgamesh Pharmaceuticals...
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
Zacks via Yahoo Finance· 3 days agoAbbVie Inc. ABBV announced that it has signed a collaboration and option-to-license agreement with...
AbbVie widens search for next hit drug with psychiatric deal worth up to $2B
Crain s Chicago Business· 4 days agoAbbVie, which already has a growing psychiatry portfolio, is paying Gilgamesh $65 million upfront and as much as $1.95 billion in aggregate option fees and milestones in the ...
Weekly Recap: 11 Press Releases You Might Have Missed
FOX 23 News Albany· 9 hours agoA roundup of the most newsworthy press releases from PR Newswire this week, including Pizza Hut's entry to the burger business and Squarespace's plans to go private. NEW YORK, May 17, 2024 / ...
X-Men '97: Will an MCU Favorite Have a Larger Role in Season 2?
Comic Book· 2 days agoThe season finale of X-Men '97 was released on Disney+ today, and it set up a bunch of excitement...
See What Shearling Leather Jackets Your Favorite Celebrities are Sporting This Season
Digital Journal· 3 days agoWhen winter approaches, it’s time for the sheer jacket to take the stage! Shearling is famous for its luxurious warmth and fashionable look; it has been an essential element of high fashion ...